Psychiatry · Saint Louis, MO
NPI
1942208715
Since 2005
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
763 S New Ballas Rd, Suite 110
Saint Louis, MO, 63141
Phone (314) 569-1717
Medicare paid, 2024
$30K
448 services
Medicare patients, 2024
157
Average age 62
Drug cost, 2024
$1.4M
5,340 prescriptions
Company payments, 2025
$4,317
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohd A Malik was code 99443 (telephone services), 133 times for 81 patients. In total Mohd A Malik billed 448 services in 12 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99443 Telephone Services | Office | 133 | 81 | $77.50 | $10K |
| 99214 Office E&M - Established | Office | 108 | 52 | $82.08 | $8,865 |
| 99442 Telephone Services | Office | 89 | 69 | $49.14 | $4,373 |
| 99213 Office E&M - Established | Office | 51 | 29 | $51.14 | $2,608 |
| 90833 Psychotherapy - Nongroup | Office | 36 | 22 | $45.71 | $1,646 |
By year: 2022 $82K for 1,214 services; 2023 $53K for 698 services; 2024 $30K for 448 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohd A Malik prescribed most often to Medicare patients was Clonazepam, with 310 prescriptions and refills. In total Mohd A Malik wrote 5,340 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 310 | 350 | 88 | $1,854 |
| Quetiapine Fumarate Generic | 292 | 477 | 102 | $5,682 |
| Gabapentin Generic | 276 | 409 | 87 | $4,259 |
| Olanzapine Generic | 187 | 265 | 54 | $5,367 |
| Clozapine Generic | 185 | 199 | 22 | $9,458 |
| Lamotrigine Generic | 168 | 331 | 65 | $2,283 |
| Bupropion Xl Bupropion Hcl | 164 | 284 | 64 | $3,983 |
| Trazodone Hcl Generic | 139 | 253 | 52 | $1,586 |
| Caplyta Lumateperone Tosylate | 135 | 163 | 40 | $265K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 124 | 127 | 27 | $19K |
| Duloxetine Hcl Generic | 121 | 195 | 44 | $3,400 |
| Mirtazapine Generic | 117 | 217 | 48 | $1,601 |
| Alprazolam Generic | 114 | 122 | 40 | $444 |
| Lurasidone Hcl Generic | 107 | 145 | 34 | $15K |
| Lithium Carbonate Er Lithium Carbonate | 107 | 168 | 36 | $1,257 |
Brand drugs: 646 claims; generic drugs: 4,694 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohd A Malik $4,317 ($1,017 in general payments such as food, travel and fees and $3,300 for research) from 10 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $3,300.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $3,300 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 18 | $548 |
| Neuronetics, Inc. STIM | 3 | $246 |
| Lundbeck LLC | 1 | $92.5 |
| Alkermes, Inc. ALKS | 2 | $55.59 |
| Supernus Pharmaceuticals, Inc. SUPN | 2 | $36.99 |
| Axsome Therapeutics, Inc. AXSM | 1 | $19.24 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $18.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.